Bethany Sensenig
Director · 4 filings · Latest: Jun 11, 2026
Alpha Cognition Inc.
KalVista Pharmaceuticals, Inc.
SUPERNUS PHARMACEUTICALS, INC.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
SUPN | Bethany Sensenig | Director | Feb 19, 2026 | Sale | $51.01 | 4,475 | $228.3K | 0 | |
SUPN | Bethany Sensenig | Director | Feb 19, 2026 | Option Exercise | $0.00 | 4,475 | — | 4,475 | |
SUPN | BETHANY SENSENIG | — | Feb 19, 2026 | Proposed Sale | $50.20 | 4,475 | $224.6K | — | |
SUPN | BETHANY SENSENIG | — | Aug 14, 2025 | Proposed Sale | $42.64 | 5,369 | $228.9K | — |